Dhanvantri Jeevan Rekha Ltd (BSE: 531043) is a Meerut, Uttar Pradesh-based company in the Hospitals and Healthcare Centers industry. With a market capitalisation of ₹9 Cr, it ranks #4,845 by market cap among the 6,197 Indian listed companies on FinBizNet, and #43 of 46 in Hospitals and Healthcare Centers. At ₹22.03 (as of 16 Nov 2026), the share price is 26.6% below its 52-week high of ₹30.00 and 12.8% above its 52-week low of ₹19.53. The share price is down 18.0% over one year and down 18.4% over three months.
| Current Price | ₹22.03 |
|---|---|
| Market Cap | ₹9 Cr |
| BSE Code | 531043 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Hospitals and Healthcare Centers |
| P/E Ratio | 22 |
| Return on Equity | 5.16% |
| Return on Assets | 1.17% |
| 52-Week Range | ₹19.53 – ₹30.00 |
| 1-Year Price Change | -18.0% |
| 3-Month Price Change | -18.4% |
| Beta (1Y) | -0.1 |
| Dividend Yield | 0.00% |
| Headquarters | Meerut, Uttar Pradesh |
| Website | www.djrl.org.in |
Delivery averaged 96.9% of traded volume across 11 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Dhanvantri Jeevan Rekha Limited engages in the provision of medical and healthcare services in India. It offers diagnostic and therapeutic services. The company also provides specialty services, such as Cardiology, Gastroenterology, Neurology, Urology, Nephrology, Internal Medicine, Pulmonology, and other diagnostic services. In addition, the company operates a cath lab that provides angiography, angioplasty, pacemaker implantation, valvuloplasty services, etc. Dhanvantri Jeevan Rekha Limited was incorporated in 1993 and is based in Meerut, India.
1. Healthcare Facilities & Services-This segment operates a hospital and medical diagnostic centre. It provides diagnostic and therapeutic services in the areas of urology, gastroenterology, cardiology, neurology, and radiology, including magnetic resonance imaging.
1. Healthcare Facilities & Services-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | ₹1,23,712 Cr | 63 | 21.50% | ₹7,615 Cr | +11.6% |
| Max Healthcare Institute Ltd | ₹91,978 Cr | 63.9 | 14.33% | ₹2,569 Cr | -16.6% |
| Manipal Health Enterprises Ltd | ₹89,110 Cr | 88.4 | — | ₹3,399 Cr | — |
| Aster Dm Healthcare Limited (Asterdm) | ₹63,041 Cr | 97.6 | 10.07% | ₹2,829 Cr | +4.3% |
| Fortis Healthcare Ltd. | ₹58,283 Cr | 55.1 | 11.01% | ₹2,735 Cr | -25.1% |
| Global Health Ltd (Medanta) | ₹38,422 Cr | 69.7 | 15.03% | ₹1,469 Cr | +16.2% |
| Narayana Hrudayalaya Limited | ₹37,907 Cr | 46.2 | 19.85% | ₹2,844 Cr | +2.8% |
| Krishna Institute Of Medical Science (KIMS) | ₹29,056 Cr | 120.6 | 9.72% | ₹1,344 Cr | +0.2% |
| Dhanvantri Jeevan Rekha Ltd | ₹9 Cr | 22 | 5.16% | — | -18.0% |
Listed by market capitalisation. Ratios are shown for context only.
Dhanvantri Jeevan Rekha Ltd is trading at ₹22.03, with a market capitalisation of ₹9 Cr.
Dhanvantri Jeevan Rekha Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).
Dhanvantri Jeevan Rekha Ltd has a P/E of 22 and a return on equity of 5.16%.
Dhanvantri Jeevan Rekha Ltd is listed on the BSE under the scrip code 531043.
Dhanvantri Jeevan Rekha Ltd's share price is down 18.0% over one year and down 18.4% over three months. Its 52-week range is ₹19.53 to ₹30.00.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.